Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

NCT00003670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: arzoxifene hydrochloride

Sponsor

Eli Lilly and Company